BIOMARKER:

TYMS underexpression

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

›

TYMS underexpression	Colorectal Cancer	TYMS underexpression	Colorectal Cancer	bevacizumab Sensitive: C3 – Early Trials bevacizumab Sensitive : C3	bevacizumab Sensitive: C3 – Early Trials bevacizumab Sensitive : C3
TYMS underexpression	Colorectal Cancer	TYMS underexpression	Colorectal Cancer	arfolitixorin Sensitive: C3 – Early Trials arfolitixorin Sensitive : C3	arfolitixorin Sensitive: C3 – Early Trials arfolitixorin Sensitive : C3
TYMS underexpression	Colorectal Cancer	TYMS underexpression	Colorectal Cancer	FOLFIRI Sensitive: C3 – Early Trials FOLFIRI Sensitive : C3	FOLFIRI Sensitive: C3 – Early Trials FOLFIRI Sensitive : C3
TYMS underexpression	Colorectal Cancer	TYMS underexpression	Colorectal Cancer	FOLFOX Sensitive: C3 – Early Trials FOLFOX Sensitive : C3	FOLFOX Sensitive: C3 – Early Trials FOLFOX Sensitive : C3
TYMS underexpression	Soft Tissue Sarcoma	TYMS underexpression	Soft Tissue Sarcoma	cisplatin + pemetrexed Sensitive: C3 – Early Trials cisplatin + pemetrexed Sensitive : C3	cisplatin + pemetrexed Sensitive: C3 – Early Trials cisplatin + pemetrexed Sensitive : C3